Search results for "Brea"

showing 10 items of 4298 documents

ASPHER Statement

2021

Submitted by Agostinho Macau (arm@ucp.pt) on 2021-09-14T08:06:58Z No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Made available in DSpace on 2021-09-14T08:06:58Z (GMT). No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Previous issue date: 2021-08-23 info:eu-repo/semantics/publishedVersion

2019-20 coronavirus outbreakmedicine.medical_specialtyHealth (social science)Coronavirus disease 2019 (COVID-19)pandemic ; winter planning ; COVID-19 ; Public Health ; third waveStatement (logic)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Library sciencePolitical sciencePandemicmedicineHumansThird waveWinter planningPandemicPublic healthPublic Health ArchivePublic Health Environmental and Occupational HealthCOVID-19Déjà vuCommentarySeasonsPublic HealthPublic aspects of medicineRA1-1270Third waveInternational Journal of Public Health
researchProduct

Comment on “ COVID ‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action”

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDermatologyBetacoronavirusPsoriasisMedicineHumansPsoriasisLimit (mathematics)LettersLetters to the EditorPandemicsLetter to the Editorbusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseaseDermatologyAction (philosophy)businessCoronavirus InfectionsCoronavirus InfectionsImmunosuppressive AgentsDermatologic Therapy
researchProduct

Immunosuppressive treatment for systemic sclerosis—Therapeutic challenges during the COVID ‐19 pandemic

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)systemic sclerosisPneumonia ViralDermatologySclerodermaCOVID‐19Risk FactorsPsoriasisPandemicmedicineHumansPsoriasisLettersIntensive care medicinePandemicsImmunosuppressive treatmentbusiness.industryCOVID-19immunosuppressive treatmentGeneral Medicinemedicine.diseasePneumoniaCoronavirus InfectionsbusinessImmunosuppressive AgentsCoronavirus InfectionsDermatologic Therapy
researchProduct

Cutaneous manifestation of COVID‐19 reporting from Middle‐Eastern countries: A point of view!

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyMiddle EastCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINECOVID-19DermatologySkin DiseasesBetacoronavirusMiddle EastFamily medicinePandemicmedicineHumansCoronavirus InfectionsbusinessPandemicsInternational Journal of Dermatology
researchProduct

Toxicity as prime selection criterion among SARS-active herbal medications

2021

We present here a new selection criterion for prioritizing research on efficacious drugs for the fight against COVID-19: the relative toxicity versus safety of herbal medications, which were effective against SARS in the 2002/2003 epidemic. We rank these medicines according to their toxicity versus safety as basis for preferential rapid research on their potential in the treatment of COVID-19. The data demonstrate that from toxicological information nothing speaks against immediate investigation on, followed by rapid implementation of Lonicera japonica, Morus alba, Forsythia suspensa, and Codonopsis spec. for treatment of COVID-19 patients. Glycyrrhiza spec. and Panax ginseng are ranked in …

2019-20 coronavirus outbreakmedicine.medical_specialtyRelative toxicityCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pharmaceutical ScienceReviewSARS-CoV-2 severe acute respiratory syndrome coronavirus 203 medical and health sciencesCytochrome P450 Phytochemicals0302 clinical medicineSOD superoxide dismutaseDrug DiscoveryMedicineAnimalsHumansOral applicationIKK inhibitor of κB kinase030304 developmental biologyPharmacologyRational phytotherapy0303 health sciencesPublic healthCOVID-19 Coronavirus disease 2019JNK c-Jun N-terminale kinaseNO nitric oxidePlants MedicinalTraditional medicineToxicityACE2 angiotensin converting enzyme 2business.industrySARS-CoV-2Public healthCOVID-19Th2 T helper cells type 2NF-κB nuclear factor- κ B cellsComplementary and alternative medicine030220 oncology & carcinogenesisToxicityMolecular MedicineCYP cytochrome P450 monooxygenaseHIV-1 human immunodeficiency virus 1businessSelection criterionMAPK mitogen-activated protein kinaseDrugs Chinese HerbalPhytomedicine
researchProduct

Conspiracy Beliefs Are Related to the Use of Smartphones behind the Wheel

2021

The belief in conspiracy theories predicts behaviors related to public health such as the willingness to receive vaccines. This study applies a similar approach to an aspect of road safety: the use of smartphones while driving. A representative sample of 1706 subjects answered a series of questions related to what can be regarded as erroneous or conspiracy beliefs against restricting or banning the use of smartphones while driving. The results show that those having such conspiracy beliefs reported a greater use of smartphones behind the wheel.

2019-20 coronavirus outbreakmedicine.medical_specialtyadulthoodCoronavirus disease 2019 (COVID-19)Health Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Applied psychology050105 experimental psychologyArticle0502 economics and businessdevelopmental psychologydrivingmedicineHumansrisk behaviour0501 psychology and cognitive sciences050210 logistics & transportationRisk behaviourPublic health05 social sciencesPublic Health Environmental and Occupational HealthRCOVID-19smartphonesBehind the wheelMobile phoneMedicinePublic HealthSmartphonePsychologyRisk takingInternational Journal of Environmental Research and Public Health
researchProduct

Medical dominos: impact of COVID-19 care on the health of the population

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyeducation.field_of_studyCoronavirus disease 2019 (COVID-19)business.industryPain medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationMEDLINECOVID-19Critical Care and Intensive Care MedicineAnesthesiologyEmergency medicinemedicineeducationbusiness
researchProduct

In Reply – Association of Renin Angiotensin System Blockers with Outcomes in Patients With COVID-19

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Renin-Angiotensin COVID-19 hypertensionCOVID-19General MedicineRenin-Angiotensin SystemBetacoronavirusInternal medicineRenin–angiotensin systemHumansMedicineIn patientCoronavirus InfectionsbusinessPandemicsRenin-AngiotensinLetter to the EditorMayo Clinic Proceedings
researchProduct

Cutaneous manifestations in COVID‐19: a new contribution

2020

Abstract We have read with great interest Dr Recalcati’s review about skin manifestations in COVID‐19 as it is the first report on this subject1. In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases2. However, from the trained eyes of a dermatologist, this percentage may be higher.

2019-20 coronavirus outbreakmedicine.medical_specialtyskinCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyLetter to Editor030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCOVID‐19medicineSkin manifestationscutaneous manifestationsbusiness.industrycutaneousmedicine.diseaseDermatologyRashPneumoniaInfectious Diseases030220 oncology & carcinogenesisDifferential diagnosismedicine.symptombusinessCoronavirus InfectionsJournal of the European Academy of Dermatology and Venereology
researchProduct

Paediatric Emergencies During the COVID-19 Pandemic

2021

The state of alarm decreed by the Spanish Government, due to the Coronavirus Disease-19 (COVID-19) pandemic, has demanded the lockdown of children and has conditioned a new organization of the Emergency Departments (ED). A pre-triage station and 2 independent circuits were established: suspected COVID-19 and not suspected COVID-19. The ED visits decreased 84,5% from pre-alarm with no increase in the level of urgencies. During the alarm state, 40.97% of the children were classified as suspected COVID-19. Fever and respiratory symptoms, used as discriminators, generated 2 groups of patients with different characteristics. Although the interruption of sports activities and isolation of childr…

2019-20 coronavirus outbreakpaediatricIsolation (health care)Coronavirus disease 2019 (COVID-19)Primary carePediatricslockdown03 medical and health sciences0302 clinical medicine030225 pediatricsPandemicMedicineOriginal Research Article030212 general & internal medicineSports activityGovernmentAlarm statebusiness.industrylcsh:RJ1-570COVID-19lcsh:Pediatricsmedicine.diseaseemergenciesPediatrics Perinatology and Child HealthMedical emergencybusinessGlobal Pediatric Health
researchProduct